Top Markets
Coin of the day
Cambium Bio Limited Cambium Bio Limited

Cambium Bio Limited

CMB
Rank in Stocks #33320
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Share Price
$0.26800822
Market Cap
$7.89M
Change (1 day)
5.56%
Change (1 year)
11.35%
Country
AU
Trade Cambium Bio Limited (CMB)

Category

Dividend history for Cambium Bio Limited (CMB)
Cambium Bio Limited (stock symbol: CMB) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Cambium Bio Limited (CMB) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
29.00%
BE